J 2024

Prevalence of neurological complications in children hospitalized with SARS-CoV-2 infection or MIS-C in children - single center observational study

MUŽLAYOVÁ, Patrícia, Pavlína DANHOFER, Klára ŠPANĚLOVÁ, Senad KOLÁŘ, Ondřej HORÁK et. al.

Základní údaje

Originální název

Prevalence of neurological complications in children hospitalized with SARS-CoV-2 infection or MIS-C in children - single center observational study

Autoři

MUŽLAYOVÁ, Patrícia (703 Slovensko, domácí), Pavlína DANHOFER (203 Česká republika, domácí), Klára ŠPANĚLOVÁ (203 Česká republika, domácí), Senad KOLÁŘ (203 Česká republika, domácí), Ondřej HORÁK (203 Česká republika, domácí), Jozef KLUČKA (703 Slovensko, domácí), Petr ŠTOURAČ (203 Česká republika, domácí), Jan ŠENKYŘÍK (203 Česká republika, domácí), Miriam MALÁ (203 Česká republika, domácí) a Lukáš HOMOLA (203 Česká republika, domácí)

Vydání

Ceska a slovenska neurologie a neurochirurgie, PRAGUE, Czech Medical Association J.E. Purkyne, 2024, 1210-7859

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30210 Clinical neurology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 0.500 v roce 2022

Organizační jednotka

Lékařská fakulta

UT WoS

001296098700001

Klíčová slova anglicky

SARS-CoV-2 infection; MIS-C - children; neurological complications; epidemiology

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 2. 9. 2024 12:11, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused the enduring global COVID-19 pandemic, which has already begun in late 2019. The virus affects various organs, including the nervous system. This study investigates neurological complications in children with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in the South Moravia region (Czech republic), where a high COVID-19 rate among children (35.790/100.000) allows for a comprehensive analysis. Methods: Data from the University Hospital Brno (from March 2020 to February 2022) were analyzed to study two groups of hospitalized children diagnosed with COVID-19 or MIS-C: one experiencing neurological complications, and the other without neurological symptoms. The analysis included demographics, admission reasons, infection severity and progression, objective neurological findings, hospitalization details, MIS-C presence and therapies used. Descriptive statistics and statistical testing were employed to assess how individual factors influenced neurological complication rates within these groups. Results: Among 420 hospitalized children with COVID-19 or MIS-C, 26 (6.2%) had neurological complications. Preexisting neurological deficits increased the likelihood of worse outcomes (P = 0.0224). Significant differences in hospitalization length (P = 0.0012), infection severity (P = 0.0052), and outcome (P < 0.0001) occurred between groups. Conclusion: Continuous monitoring and further research on neurological complications in children with COVID-19 or MIS-C are crucial for better understanding of the course of the disease and minimize complications after infection.